AR117467A2 - PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES - Google Patents

PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES

Info

Publication number
AR117467A2
AR117467A2 ARP190103791A ARP190103791A AR117467A2 AR 117467 A2 AR117467 A2 AR 117467A2 AR P190103791 A ARP190103791 A AR P190103791A AR P190103791 A ARP190103791 A AR P190103791A AR 117467 A2 AR117467 A2 AR 117467A2
Authority
AR
Argentina
Prior art keywords
isoquinolinones
kinase activity
processes
preparing
solid forms
Prior art date
Application number
ARP190103791A
Other languages
Spanish (es)
Inventor
Jason Kropp
Benjamin S Lane
Paul Isbester
Michael Martin
Pingda Ren
Original Assignee
Infinity Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infinity Pharmaceuticals Inc filed Critical Infinity Pharmaceuticals Inc
Publication of AR117467A2 publication Critical patent/AR117467A2/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen en la presente polimorfos de compuestos químicos que modulan la actividad de quinasa, que incluye la actividad de la PI3 quinasa, y compuestos, composiciones farmacéuticas, y métodos para el tratamiento de enfermedades y afecciones asociadas con la actividad de quinasa, que incluye la actividad de la PI3 quinasa. Además se proporcionan en la presente procedimientos para la preparación de compuestos, polimorfos de los mismos, y composiciones farmacéuticas de los mismos. Reivindicación 1: Un compuesto de fórmula (1), donde el compuesto es el polimorfo que se proporciona en la presente es Forma B, Forma C, Forma D, Forma E, Forma F, Forma G, Forma H, Forma I, Forma J, o una forma amorfa de un compuesto de fórmula (1), o una sal, solvato, o hidrato del mismo; o una mezcla de dos o más de los mismos.Described herein are polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods for treating diseases and conditions associated with kinase activity, including the PI3 kinase activity. Further provided herein are methods for the preparation of compounds, polymorphs thereof, and pharmaceutical compositions thereof. Claim 1: A compound of formula (1), wherein the compound is the polymorph provided herein is Form B, Form C, Form D, Form E, Form F, Form G, Form H, Form I, Form J , or an amorphous form of a compound of formula (1), or a salt, solvate, or hydrate thereof; or a mixture of two or more of them.

ARP190103791A 2011-01-10 2019-12-19 PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES AR117467A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161431304P 2011-01-10 2011-01-10

Publications (1)

Publication Number Publication Date
AR117467A2 true AR117467A2 (en) 2021-08-11

Family

ID=77568205

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190103791A AR117467A2 (en) 2011-01-10 2019-12-19 PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES

Country Status (1)

Country Link
AR (1) AR117467A2 (en)

Similar Documents

Publication Publication Date Title
DOP2016000281A (en) IMIDAZO COMPOUNDS [4,5-C] QUINOLIN-2-ONA AND ITS USE TO TREAT CANCER
PH12016502382A1 (en) Substituted indazole compounds as irak4 inhibitors
AR084824A1 (en) PROCESSES TO PREPARE ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONAS
CU20150014A7 (en) 1,4-DISPOSED PIRIDAZINE ANALOGS AND METHODS FOR THE TREATMENT OF CONDITIONS RELATED TO THE DEFICIENCY OF SMN
UY35683A (en) POLYMORPH OF INHIBITORS OF TIROSINA KINASA OF BAZO (SYK)
CR20150472A (en) USE OF PIRAZOLOPIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3Kd-RELATED DISORDERS
BR112017010354B8 (en) TRIAZOLOPYRIMIDINE COMPOUNDS, THEIR USE, AND PHARMACEUTICAL COMPOSITION
PE20151542A1 (en) TETRAHYDROPYRROTHIAZINE COMPOUNDS
CR20140301A (en) BETULINA DERIVATIVES
EA201592144A1 (en) PHENOL DERIVATIVE, METHOD FOR ITS PREPARATION AND ITS APPLICATION IN MEDICINE
CO2021005532A2 (en) Quinoline derivatives as inhibitors of integrin alpha4beta7
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
EA201590520A1 (en) PHARMACEUTICAL COMPOSITION WITH COATING CONTAINING REGORAPHENIB
AR092809A1 (en) 3,5-DIAMINOPIRAZOL AS A QUINASE INHIBITOR
ECSP14007965A (en) FORMULATIONS OF (+) - 2- [1- (3-ETOXY-4-METOXY-PHENYL) -2-METANSULPHONYL-ETHYL] -4-ACETYL AMINOISOINDOLIN-1, 3-DIONA
EA201492170A1 (en) NEW CYPRIDE N-PYRIDINYLAMIDES SUBSTITUTED AS A KINAZ INHIBITOR
NI201600014A (en) COMPOUNDS AND COMPOSITIONS AS MEK INHIBITORS.
DOP2016000276A (en) 2-AMINO-6-METHYL-4,4a, 5,6-TETRAHYDROPIRANE [3,4-d] [1,3] TIAZIN-8a (8H) -IL-1,3-TIAZOL-4-ILAMIDAS
CR20130693A (en) TYPICAL ORTALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB
UY36123A (en) CARBOXAMIDE DERIVATIVES
UY36124A (en) CARBOXAMIDE DERIVATIVES
BR112019004236A2 (en) compounds to treat diseases associated with mitochondrial dysfunction
EA201891682A1 (en) AZACYCLIC AMID DERIVATIVE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL APPLICATION
BR112017021583A2 (en) Methods for treating inflammatory disorders
UY35183A (en) TYPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB